首页 | 本学科首页   官方微博 | 高级检索  
     


Use of Intravenous Polymyxin B During Continuous Venovenous Hemodialysis
Authors:J.?C.?Sarria  author-information"  >  author-information__contact u-icon-before"  >  mailto:juan.sarria@ttuhsc.edu"   title="  juan.sarria@ttuhsc.edu"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,F.?Angulo-Pernett,R.?C.?Kimbrough,C.?S.?McVay,A.?M.?Vidal
Affiliation:(1) Department of Internal Medicine, Division of Infectious Diseases and Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, USA
Abstract:Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号